Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA,
Urol Int. 2021;105(1-2):131-136. doi: 10.1159/000510320. Epub 2020 Oct 16.
The aim of the study was to report on the presentation and outcomes of vesicular cystitis (VC), a chronic cystitis exhibiting translucent bladder mucosal vesicles, among women with antibiotic-refractory recurrent urinary tract infections (RUTIs).
An analysis of our Institutional Review Board-approved series on antibiotic-refractory RUTIs was performed, selecting for documented VC lesions on cystoscopy. All patients had RUTIs defined as ≥3 urinary tract infections/year with positive urine culture. All patients were extensively treated with antibiotics with no resolution of RUTIs and were offered electrofulguration (EF) of VC lesions under anesthesia as a last resort. All patients had a 6-month post-EF office cystoscopy documenting persistence or resolution of the lesions, and a clinical outcome assessment based on RUTI frequency.
Of 482 patients, 18 (3.7%) treated during 2011-2017 met the study criteria. VC was most commonly found over the dome/anterior wall (7/18, 38%) and as pancystitis (7/18, 38%). There was often concomitant cystitis cystica of the trigone (8/18, 44%). At post-EF cystoscopy, persistence of VC was noted in 10/18 (56%) patients; 6/18 (33%) underwent repeat EF and an additional 3/18 (17%) were retreated due to new lesions after initial resolution. Two (11%) patients required simple cystectomy and urinary diversion due to RUTIs refractory to all interventions. Within a median follow-up of 2.8 years after EF, clinical cure was observed in 5/18 (28%), improvement in 10/18 (56%), and failure in 3/18 (17%) patients.
Among women with antibiotic-refractory RUTIs, VC is an infrequent and persistent form of cystitis with a predilection for non-trigonal bladder surfaces, whose management is challenging.
本研究旨在报告在抗生素难治性复发性尿路感染(RUTI)女性中出现的透明膀胱黏膜囊泡的囊泡性膀胱炎(VC)的表现和结局。
我们对机构审查委员会批准的关于抗生素难治性 RUTI 的系列研究进行了分析,选择在膀胱镜检查中记录有 VC 病变的患者。所有患者均有 RUTI,定义为每年≥3 次尿路感染,尿液培养阳性。所有患者均接受了广泛的抗生素治疗,但 RUTI 未得到缓解,并作为最后手段在麻醉下接受 VC 病变电灼术(EF)治疗。所有患者在 EF 术后 6 个月进行门诊膀胱镜检查,记录病变的持续或缓解情况,并根据 RUTI 频率进行临床结局评估。
在 482 名患者中,有 18 名(3.7%)在 2011 年至 2017 年期间接受了治疗,符合研究标准。VC 最常见于穹窿/前壁(7/18,38%)和全膀胱炎(7/18,38%)。三角区经常伴有囊状膀胱炎(8/18,44%)。EF 术后膀胱镜检查时,18 例患者中有 10 例(56%)VC 持续存在;6 例(33%)再次接受 EF 治疗,另外 3 例(17%)在初始缓解后因新病变而再次治疗。2 例(11%)患者由于所有干预措施均无效而需要进行简单的膀胱切除术和尿流改道。EF 后中位随访 2.8 年,5/18 例(28%)患者临床治愈,10/18 例(56%)患者病情改善,3/18 例(17%)患者治疗失败。
在抗生素难治性 RUTI 女性中,VC 是一种罕见且持续存在的膀胱炎形式,主要发生于非三角区膀胱表面,其治疗具有挑战性。